|
“…evaluating palbociclib (CDK4/6) treatment outcome …”
https://www.biospace.com/article/rel...cer-treatment/
https://clincancerres.aacrjournals.o.../2131.abstract
https://www.nature.com/articles/s41598-020-61416-1
I need to be more rigorous in monitoring/reading research, these articles were published in Jannuary/2020. I believe they are filing for FDA approval of Divitum.
Nguyen
|